09 - 10 April, 2019 | Novotel Sydney Central, Sydney, Australia

Ian Nisbet


Co-Founder and Corporate Advisor
Cartherics Pty Ltd

 Conference Day One: Tuesday, 9th April 2019

Tuesday, April 9th, 2019


11:30 AM CASE STUDY: Accelerating R&D in the Biopharmaceutical Industry through the Cooperative Research Centre - Project (CRC-P) scheme

The CRC-P scheme is designed to encourage collaboration between industry and academia on the achievement of three year, industry led projects. In 2017, Catherics Pty Ltd was the Lead Participant in a successful CRC-P application, receiving Commonwealth funding of almost $3M in support of a $12M project to develop allogeneic stem cell cancer immunotherapies. The other Participants in the CRC-P are Mesoblast Ltd, Cell Therapies Pty Ltd, Hudson Institute of Medical Research and Monash University. The project received ~$3 million from government funding, with ~$9 million being committed in cash and in kind contributions from the Participants over the three year project.

This session will describe how the CRC-P scheme encourages collaboration between universities and Industry, bringing them together to focus on an industry-led problem and drive research impact in the biopharmaceutical industry.

  • Leveraging the CRC-P scheme to accelerate industry-led projects and build collaboration between industry and academia
  • Overcoming cultural differences between key stakeholders to deliver impactful research
  • Factors to measuring success to prove ROI to Government funding

Check out the incredible speaker line-up to see who will be joining Ian.

Download The Latest Agenda